Therefore, this study hypothesized that the DDIT4-mTOR pathway is involved in regulating the ratio between the M1 and M2 phenotypes of macrophages, inhibiting the expression of inflammation-related factors, reducing the apoptosis of podocytes, and playing a role in the treatment of DKD. The gene discussed is MTOR; the disease is diabetic kidney disease.